Cost of Reaching Defined HbA1c Target Using Canagliflozin Compared to Dapagliflozin as Add-On to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) in the United Arab Emirates (UAE)

Cost of Reaching Defined HbA1c Target Using Canagliflozin Compared to Dapagliflozin as Add-On to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) in the United Arab Emirates (UAE)

2015 Value Health

Schubert, A. | Nielsen, A. T. | El Khoury, A. | Kamal, A. | Taieb, V. | Volume: 18, Issue: 7, Pages: A608,
https://www.doi.org/10.1016/j.jval.2015.09.2100